PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 59 filers reported holding PRELUDE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $151,979 | -39.5% | 49,184 | -11.9% | 0.00% | – |
| Q2 2023 | $251,271 | -6.7% | 55,838 | +18.2% | 0.00% | – |
| Q1 2023 | $269,319 | -34.4% | 47,249 | -30.5% | 0.00% | – |
| Q4 2022 | $410,750 | -21.2% | 68,005 | -13.8% | 0.00% | -100.0% |
| Q3 2022 | $521,000 | -13.9% | 78,881 | -31.9% | 0.00% | 0.0% |
| Q2 2022 | $605,000 | +271.2% | 115,867 | +390.7% | 0.00% | – |
| Q1 2022 | $163,000 | -70.0% | 23,611 | +88.2% | 0.00% | -100.0% |
| Q1 2021 | $544,000 | – | 12,546 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $69,274,000 | 1.12% |
| Baker Brothers Advisors | 10,123,824 | $69,854,000 | 0.40% |
| HHLR ADVISORS, LTD. | 583,333 | $4,025,000 | 0.08% |
| Rock Springs Capital Management LP | 368,959 | $2,546,000 | 0.06% |
| PDT Partners, LLC | 71,822 | $496,000 | 0.04% |
| Virtus ETF Advisers LLC | 13,048 | $90,000 | 0.04% |
| Corton Capital Inc. | 10,918 | $75,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 23,201 | $160,000 | 0.02% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,238 | $167,000 | 0.01% |
| IndexIQ Advisors LLC | 56,750 | $392,000 | 0.01% |